STAT
JUNE 15, 2024
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
The Guardian - Pharmaceutical Industry
JUNE 15, 2024
Former infectious disease head says big pharma tried to poach him while he was combating coronavirus Before retiring from his lengthy run as the US government’s top infectious disease doctor, major pharmaceutical companies tried to lure him away from his post by offering him seven-figure jobs – but Anthony Fauci turned them down because he “cared about … the health of the country” too much, he says in a new interview.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier.
Fuld & Company Blog
JUNE 15, 2024
This month we focus on helping you sharpen your competitive edge with leading trends in CI and storytelling, and we discuss some of the latest plays we’re seeing in renewable energy. Our upcoming two-part webinar series, “Essential Skills for Competitive Intelligence Professionals” is open to competitive intelligence professionals, market researchers, business analysts, and consultants looking to boost their CI skills.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier.
Board Vitals - Pharmacist
JUNE 15, 2024
Embarking on a career in obstetrics and gynecology requires a thorough understanding of key topics tested on the OBGYN qualifying examination. This exam is a critical step for aspiring OBGYNs, testing a wide range of skills and knowledge essential to the field. Let’s take a closer look at the content covered on the examination and explore different strategies for preparation.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
EMCrit Project
JUNE 15, 2024
more on PREOXI EMCrit Project by Scott Weingart, MD FCCM.
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier.
Pharmacy Times
JUNE 15, 2024
The study results also found that exposure to tree canopy area may protect children from asthma development; however, efficacy decreased as weed pollen exposure increased.
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Express Pharma
JUNE 15, 2024
India, synonymous with the “pharmacy of the world” has rightfully earned the title, owing to its remarkable contribution in supplying 20 per cent of the global generic medicines, along with 60 per cent of the total vaccine demand worldwide. From the Covid-19 pandemic to the floods in Sri Lanka in 2017, India has made significant contributions in assisting several nations, irrespective of geographies – especially in terms of providing low-cost vaccines and other medical aid.
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier.
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier.
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for REXULTI Rexulti is a drug marketed by Otsuka and is included in one NDA. It is available from two suppliers.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for DUOBRII Duobrii is a drug marketed by Bausch and is included in one NDA. It is available from one supplier.
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Bausch and is included in one NDA. It is available from one supplier.
Drug Patent Watch
JUNE 15, 2024
This chart shows the pharmaceutical companies with the most patents in New Zealand.
Expert insights. Personalized for you.
233 
Let's personalize your content